DrugPatentWatch Database Preview
Astral Company Profile
» See Plans and Pricing
What is the competitive landscape for ASTRAL, and what generic and branded alternatives to ASTRAL drugs are available?
ASTRAL has five approved drugs.
Summary for Astral
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 3 |
| NDAs: | 5 |
Drugs and US Patents for Astral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astral | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 212287-001 | Jul 29, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Astral | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 091049-003 | Jun 11, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Astral | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 212287-003 | Jul 29, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Astral | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 091049-002 | Jun 11, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
